Study design
MYOCARDIAL INFARCTION
A prospective randomized double blinded trial has been designed to evaluate the effect of sirolimus-eluting stent (Ultimaster®, Terumo Corporation, Tokyo, Japan) implantation into the maximally dilated coronary artery. The trial protocol has been registered at A flow-chart for the study. MI, myocardial infarction; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent; TVR, target vessel revascularization